Synergistic effect of Avemar on proinflammatory cytokine production and Ras-mediated cell activation

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 515-528

  Telekes, András ^a   Kiss Tóth, Endre ^b   Nagy, Tünde ^c   Qwarnstrom, Eva E ^b   Kúsz, Erzsébet ^c   Polgár, Timea ^b,c   Resetár, Ákos ^d   Dower, Steven K ^b   Duda, Erno ^c,e  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

^d Biromedicina First Hungarian Corporation for Cancer Research and Oncology   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Avemar; Cytokine; ICAM; NF B; Synergism; TNF

Indexed keywords

AVEMAR; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WHEAT GERM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG POTENTIATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOID CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; TUMOR CELL; WHEAT GERM;

TRITICUM AESTIVUM;

EID: 25444475470     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.096     Document Type: Conference Paper

References (30)

1. HIDVÉGI, M., E. RÁŚO, R. TÖMÖSKÖZI- FARKAS, et al. 1999. MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer Biother. Radiopharm. 14: 277-289.
2. FAJKA-BOJA, R., M. HIDVÉGI, Y. SHOENFELD, et al. 2002. Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines. Int. J. Oncol. 20: 563-570.
3. ILLMER, C., S. MADLENER, Z. HORVATH, et al. 2005. Immunologic and biochemical effects of the fermented wheat germ extract Avemar. Exp. Biol. Med. 230: 144-149.
4. ZALATNAI, A., K. LAPIS, B. SZENDE, et al. 2001. Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats. Carcinogenesis 22: 1649-1652.
5. MARCSEK, Z., ZS. KOCSIS, M. JAKAB, et al. 2004. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment. Cancer Biother. Radiopharm. 19: 746-753.
6. COMÍN-ANDUIX, B., L.G. BOROS, S. MARIN, et al. 2002. Fermented wheat germ extract inhibits glycolysis/pentose cycle enyzmes and induces apoptosis through poly (ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. J. Biol. Chem. 277: 46408-46414.
7. BOROS, L.G., K. LAPIS, B. SZENDE, et al. 2001. Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells. Pancreas 23: 141-147.
8. MOLEY, K.H. & M.M. MUECKLER. 2000. Glucose transport and apoptosis. Apoptosis 5: 99-105.
9. KANSARA, M. & M.V. BERRIDGE. 2004. Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation. Anticancer Res. 24: 2503-2510
10. HIDVÉGI, M., E. RÁSÓ, R. TÖMÖSKÖZI- FARKAS, et al. 1999. Effect of MSC on immune response of mice. Immunopharmacology 41: 183-186.
11. EHRENFELD, M., M. BLANK, Y. SHOENFELD, et al. 2001. AVEMAR (a new benzoquinone-containing natural product) administration interferes with the Th2 response in experimental SLE and promotes amelioration of the disease. Lupus 10: 622-627.
12. JAKAB, F.,Y. SHOENFELD, Á. BALOGH, et al. 2003. A medical nutriment has supportive value in the treatment of colorectal cancer. Br. J. Cancer 89: 465-469.
13. CHEN, G. & D.V. GOEDDEL. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
14. GYORFI, Z., S. BENKO, E. KÚSZ, et al. 1997. Highly increased TNF sensitivity of tumor cells expressing the yeast delta 9-desaturase gene. Biochem. Biophys. Res. Commun. 2412: 465-470.
15. DENIYOT, F. & R. LANG. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 892: 271-277.
16. HOBBS, M.V., W.O. WEIGLE, D.J. NOONAN, et al. 1993. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol. 150: 3602-3614.
17. KISS-TÓTH, E., F.M. GUESDON, D.H. WYLLIE, et al. 2000. A novel mammalian expression screen exploiting green fluorescent protein-based transcription detection in single cells. J. Immunol. Methods 239: 125-135.
18. GRIFFIOEN, A.W., C.A. DAMEN, G.H. BLIJHAM, et al. 1996. Tumor angiogenesis is accompanied by decreased inflammatory response of tumor-associated endothelium. Blood 882: 667-673.
19. VERMEULEN, K., Z.N. BERNEMAN & D.R. VAN BOCKSTAELE. 2003. Cell cycle and apoptosis. Cell Proliferat. 36: 165-175.
20. SONENSHEIM, G.E. 1997. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8: 113-119.
21. DOWNWARD, J. 1998. Ras signalling and apoptosis. Curr. Opin. Genet. Dev. 8: 49-54.
22. BOURS, V, G. BONIZZI, M. BENTIRES-ALI, et al. 2000. NF-kappa B activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment. Toxicology 153: 27-38.
23. JOYCE, D., C. ALBANESE, J. STEER, et al. 2001. NF-kappa B and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12: 73-90.
24. BAZZONI, F. & B. BEUTLER. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334: 1717-1725.
25. MAYO, M.W. & A.S. BALDWIN. 2000. The transcription factor NF-kappa B: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470: M55-62.
26. AKIRA, S., T. HIRANO, T. TAGA, et al. 1990. IL 6 and related molecules (IL 1 and TNF). FASEB J. 4: 2860-2867.
27. GYGER, M., C. PERRAULT, R. BELANGER, et al. 1985. Chronic myeloid leukemia with an unusual simple variant translocation: t(22;22)(q13;q11). Acta Hematol.-Basel 73: 193-195.
28. BENTLEY, J., I. WALKER, E. MCINTOSH, et al 2001. Glucose transport regulation by p210 Bcr-Abl in a chronic myeloid leukaemia model. Br. J. Haematol. 112: 212-215.
29. BOREN, J. M. CASCANTE, S. MARIN, et al. 2001. Gleevec (ST1571) influences meta-bolic enzyme activities and glucose carbon flow towards nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem. 276: 27747-37753.
30. BOROS, G.L. M. CASCANTE & W.-N. P. LEE. 2002. Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discovery Today 7: 18-26.